Opening book details…
Can I read Biosimilars and Interchangeable Biologics : Strategic Elements on EtoBox?
Biosimilars and Interchangeable Biologics : Strategic Elements by Sarfaraz Khan Niazi is a nonfiction available to read on EtoBox.
What is Biosimilars and Interchangeable Biologics : Strategic Elements about?
What’s the Deal with Biosimilars? Biosimilars are gaining momentum as new protein therapeutic candidates that can help fill a vital need in the healthcare industry. The biological drugs are produced by recombinant DNA technology that allows for large-scale production and an overall reduction time in costs and development. Part of a two-volume set that covers varying aspects of biosimilars, Biosimilars and Interchangeable Biologics: Strategic Elements explores the strategic planning side of biosimilar drugs and targets issues surrounding biosimilars that are linked to legal matters. This includes principal patents and intellectual property, regulatory pathways, and concerns about affordability on a global scale. It addresses the complexity of biosimilar products, and it discusses the utilization of biosimilars and related biological drugs in expanding world markets. Of specific interest to practitioners, researchers, and scientists in the biopharmaceutical industry, this volume examines the science, technology, finance, legality, ethics, and politics of biosimilar drugs. It considers strategic planning elements that include an overall understanding of the history and the current sta
Who reads Biosimilars and Interchangeable Biologics : Strategic Elements?
It is typically read by self-directed learners exploring a subject in depth.
Common subject areas: history, science, philosophy, social sciences.
- Author
- Sarfaraz Khan Niazi
- Publisher
- Taylor & Francis/CRC Press
- Published
- 2016
- Language
- EN
- ISBN
- 9780367267476
- Category
- nonfiction
- Subjects
- Medical, Technology, Business
Other editions & translations
More by Sarfaraz Khan Niazi
Browse all works by Sarfaraz Khan Niazi
Similar books
- BIOLOGICS AND BIOSIMILARS : Drug Discovery and Clinical Applications — Xiaodong Feng; Hong-Guang Xie; Ashim Malhotra; Catherine F. Yang (2022)
- Biosimilars: A Critical Review of Development, Regulatory Landscape, and Clinical Implications — Ankit Monga & Gagan & Pragya Jamwal & Sumit Sharma & Amanpreet Kaur (2025)
- Biosimilars [recurso electrónico] A New Generation of Biologics — Prugnaud, Jean-Louis; Trouvin, Jean-Hugues (2013)
- Biologics, Biosimilars, and Biobetters : an Introduction for Pharmacists, Physicians, and Other Health Practitioners — Iqbal Ramzan (2021)
- Biosimilars: Design and Analysis of Follow-on Biologics (Chapman & Hall/CRC Biostatistics) — Shein-Chung Chow (2013)
- Lyophilized Biologics and Vaccines : Modality-Based Approaches — Manmohan Singh Dushyant Varshney (2015)